Wook Kim
Director of Finance/CFO bij HLB GLOBAL CO., LTD.
Profiel
Wook Kim is currently the Chief Financial Officer & Director at HLB GLOBAL Co., Ltd.
and also holds a Director position at HLB Co., Ltd.
He previously worked as a Director at Elevar Therapeutics, Inc. Mr. Kim completed his undergraduate degree at Korea University.
Actieve functies van Wook Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| HLB CO., LTD. | Director/Board Member | - |
| HLB GLOBAL CO., LTD. | Director of Finance/CFO | 01-08-2018 |
Eerdere bekende functies van Wook Kim
| Bedrijven | Functie | Einde |
|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
Opleiding van Wook Kim
| Korea University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HLB GLOBAL CO., LTD. | Energy Minerals |
| HLB CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
